Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-270-0 | CAS number: 134620-00-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Study performed between 21 February and 27 March 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- OECD guidleine study, to GLP, conducted prior to the LLNA. No reporting of test purity and stability.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study conducted in 1997
Test material
- Reference substance name:
- Tetraamminepalladium (II) hydrogen carbonate
- IUPAC Name:
- Tetraamminepalladium (II) hydrogen carbonate
- Reference substance name:
- 134620-00-1
- Cas Number:
- 134620-00-1
- IUPAC Name:
- 134620-00-1
- Details on test material:
- - Name of test material (as cited in study report): Tetrammine palladium hydrogen carbonate
- Substance type: no data
- Physical state: no data
- Analytical purity: no data
- Lot/batch No.: no data
- Stability under test conditions: no data
- Storage condition of test material: no data
Constituent 1
Constituent 2
- Specific details on test material used for the study:
TEST MATERIAL
- Physical state: Pale yellow powder
- Source and lot/batch No.of test material: DD0274
- Expiration date of the lot/batch: no data
- Purity test date: no data
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
- Stability under test conditions: no data
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- not specified
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Ltd, Staffordshire, UK
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 374-425 g
- Fasting period before study: no data
- Housing: singly or in pairs in solid-floor polypropylene cages furnished with woodflakes
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-22
- Humidity (%): 49-68
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: no data
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- arachis oil
- Concentration / amount:
- 0.01% intradermal induction (with and without Freund's Complete Adjuvant (FCA)), 5% topical induction, and 1 and 2% topical challenge
Challenge
- Route:
- other: epicutaneous, but no further details in study report on whether occlusive or semi-occlusive
- Vehicle:
- arachis oil
- Concentration / amount:
- 1 and 2% topical challenge
- No. of animals per dose:
- Ten test animals in total (and 5 controls)
- Details on study design:
- RANGE FINDING TESTS: A sighting test was carried out with six guinea pigs involving intradermal injections (induction phase) of the test material at varying concentrations between 0.01 and 5% in distilled water, a 48-hr topical (induction) application of the test material at concentrations between 0.05 and 75% (in arachis oil) in four guinea pigs, and a 24-hr topical (challenge) application at 0.5-5% (in arachis oil) in two guinea pigs. The highest concentration producing only mild to moderate dermal irritaiton was selected for the topical induction stage of the main study and the highest non-irritant concentration and one lower were selected for the challange stage.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: intradermal injection (no details in study report on numbers) and single patch test
- Exposure period: 48-hr occlusive patch test
- Test groups: ten animals in total
- Control group: five animals
- Site: shoulder region, clippped
- Frequency of applications: a row of 3 injections (0.1 ml each) were made on each side of the mid-line. One week later, on the same clipped shoulder region, the occlusive patch-test was applied and held in place for 48 hr.
- Concentrations: 0.01% intradermal induction and 5% topical induction
B. CHALLENGE EXPOSURE
- No. of exposures: Single patch tests
- Exposure period: 24-hr occlusive patch test
- Test groups: ten animals in total
- Control group: five animals
- Site: clipped flanks
- Concentrations: 1 and 2% topical challenge
- Evaluation (hr after challenge): 24 and 48-hrs after patch removal
OTHER: Bodyweights were measured on day 0 and day 24. - Challenge controls:
- Topical challenge with the test material at a concentration of 1 and 2% in arachis oil
- Positive control substance(s):
- yes
- Remarks:
- hexylcinnameldehyde 85%, 2-mercaptobenzothiazole, ethyl 4-aminobenzoate 98%, 2,4-dinitrochlorobenzene
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1 and 2%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Erythema seen in all animals at challenge with 1 and 2%. Oedema seen in seven animals at 1% and all ten animals at 2% challenge.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 1 and 2%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: Erythema seen in all animals at challenge with 1 and 2%. Oedema seen in seven animals at 1% and all ten animals at 2% challenge.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1 and 2%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No erythema or oedema seen in any of the controls
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 1 and 2%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No erythema or oedema seen in any of the controls.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1 and 2%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- Erythema recorded in all ten animals at both concentrations. Oedema was recorded in two animals at 1% and in four animals at 2%. Desquamation was also seen in two guinea pigs.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1 and 2%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: Erythema recorded in all ten animals at both concentrations. Oedema was recorded in two animals at 1% and in four animals at 2%. Desquamation was also seen in two guinea pigs..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1 and 2%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No erythema or oedema seen in any of the controls
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 1 and 2%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No erythema or oedema seen in any of the controls.
- Group:
- positive control
- Remarks on result:
- other: provided overview summary results of several positive control tests using known sensitizers demonstrate suitability of test system.
- Remarks:
- positive control materials: hexylcinnameldehyde 85%, 2-mercaptobenzothiazole, ethyl 4-aminobenzoate 98%, 2,4-dinitrochlorobenzene
Applicant's summary and conclusion
- Interpretation of results:
- Category 1A (indication of significant skin sensitising potential) based on GHS criteria
- Conclusions:
- In an in vivo guinea pig maximisation test (GPMT), conducted to GLP and according to OECD Test Guideline 406, tetraamminepalladium(II) hydrogen carbonate exhibited skin sensitising potential in all ten tested animals and was therefore classified as an extreme skin sensitiser.
- Executive summary:
Tetraamminepalladium hydrogen carbonate was assessed for its contact sensitising potential in a guinea pig maximisation test maximum test (GPMT) conducted according to OECD Test Guideline 406, and to GLP.
A group of ten animals were induced by intradermal injection (with and without Freunds Complete Adjuvant; FCA) at a concentration of 0.01% of the test material (in arachis oil) to the clipped shoulder region. One week later, at the same site, they recieved a occlusive 48 -hr patch-test at a concentration of 5% (again in arachis oil). Challenge doses of 1 and 2% (in arachis oil) were applied (occulsive patch test) 2 weeks later to the clipped flanks of treated animals and the areas examined 24 and 48 hr after patch removal for erythema, oedema and other skin reactions. A further group of five animals were used as controls, receiving the same induction procedure (involving vehicle and FCA) but without the test substance, and challenged similarly to the treatment group.
Erythema was seen in all treated animals 24- and 48-hr after challenge with 1 and 2% of the test material. Oedema was seen in seven of the treated animals at 1% and in all ten treated animals at 2%, 24-hrs after removal of the challenge patch tests. The number of animals with oedema was reduced to two and four, 48-hrs after removal of the 1 and 2% challenge patch tests, respectively. Desquamation was also seen in two guinea pigs. All animals gained weight over the study period, and body weight gains from day 0 to day 24 appeared comparable between the treated and control groups.
In summary, a maximisation test involving a topical challenge application of tetraamminepalladium(II) hydrogen carbonate at a concentration of 1 and 2% to the skin of guinea pigs produced sensitisation reactions in all ten animals; a 100% (10/10) sensitisation rate. No skin reactions were recorded oin the five controls. The test material exhibited extreme skin sensitising potential in this study.
According to EU CLP criteria (EC 1272/2008), tetraamminepalladium(II) hydrogen carbonate should be classified as a skin sensitiser (category 1A).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.